Presentation EuroPCR 2026

Cryotherapy for vulnerable plaque: a first-in-human study

Presenter: Carlos Collet

May 20, 2026

REGISTER for free or LOG IN to view this content

Diabetes

Coronary

Imaging & Physiology

IVUS/NIRS

Presentation

EuroPCR 2026

Up Next

Presentation EuroPCR 2026

Two-year outcomes of contemporary TAVI valves: LANDMARK, a randomised, non-inferiority trial

Presenter: Patrick Serruys

May 20, 2026

More slides +

Presentation EuroPCR 2026

Outcomes after TAVI with latest-generation intra- and supra-annular self-expanding valves

Presenter: Matteo Casenghi

May 20, 2026

Presentation EuroPCR 2026

Angiography-derived vs. pressure wire-based assessment in the left anterior descending coronary artery: a subgroup analysis of the ALL-RISE randomized trial

Presenter: Margaret Mcentegart

May 20, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.